View in EDS

CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition.

Saved in:

Bibliographic Details
Title:	CDK10 loss primes tumor cells for transcriptional vulnerability and sensitizes to CDK12/13 inhibition.
Authors:	Islam S; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan.; Graduate School of Medicine, Kyoto University, Kyoto, Japan., Tarumoto Y; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Takano M; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Sugino S; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Nishibuchi G; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan., Mizutani A; Chordia Therapeutics, Inc, Kanagawa, Japan., Yamakawa H; Chordia Therapeutics, Inc, Kanagawa, Japan., Morishita D; Chordia Therapeutics, Inc, Kanagawa, Japan., Yusa K; Institute for Life and Medical Sciences, Kyoto University, Kyoto, Japan. k.yusa@infront.kyoto-u.ac.jp.
Source:	Cell death & disease [Cell Death Dis] 2026 Jun 11. Date of Electronic Publication: 2026 Jun 11.
Publication Type:	Journal Article
Journal Info:	Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101524092 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2041-4889 (Electronic) NLM ISO Abbreviation: Cell Death Dis Subsets: MEDLINE
Database:	MEDLINE Ultimate

Description
ISSN:	2041-4889
DOI:	10.1038/s41419-026-08973-x